文献速递骨质疏松与代谢性骨病创伤骨科

褪黑素使用与髋部骨折的关联:一项匹配队列研究

The association of melatonin use and hip fracture: a matched cohort study.
PubMed 文献 · Osteoporos Int · 2023-04-10

该研究利用英国IQVIA医学研究数据库(2000-2018年)40岁及以上无髋部骨折或癌症史人群,采用倾向性评分匹配队列比较褪黑素起始者与催眠苯二氮䓬类起始者的髋部骨折风险。匹配后纳入9,038例(褪黑素组4,519例,苯二氮䓬组4,519例),褪黑素组髋部骨折41例,苯二氮䓬组51例;多变量校正HR为0.78(95%CI 0.51-1.17),褪黑素起始者髋部骨折风险不高于催眠苯二氮䓬类起始者。

要点

  • 褪黑素起始者髋部骨折多变量校正HR为0.78(95%CI 0.51-1.17),与催眠苯二氮䓬类起始者相比未达统计学显著。
  • 匹配后褪黑素组髋部骨折41例,催眠苯二氮䓬类组51例。
  • 髋部骨折绝对率差为-0.8/1000人年(95%CI -1.9至0.3)。

核心结论

  • 在该基于人群的队列研究中,褪黑素起始者的髋部骨折风险不高于、甚至可能低于催眠苯二氮䓬类起始者。

研究设计与样本

  • 基于英国IQVIA医学研究数据库(IMRD)2000-2018年数据,纳入40岁及以上无髋部骨折或癌症史个体,采用倾向性评分匹配队列研究比较褪黑素起始与催眠苯二氮䓬类起始的髋部骨折风险。
  • 倾向性评分匹配后共纳入9,038例患者,其中褪黑素起始者4,519例,催眠苯二氮䓬类起始者4,519例。

主要发现

  • 整个随访期间,褪黑素队列发生髋部骨折41例,催眠苯二氮䓬类队列发生51例。
  • 褪黑素起始者与催眠苯二氮䓬类起始者之间的髋部骨折绝对率差为-0.8/1000人年(95%CI -1.9至0.3)。
  • 褪黑素起始者髋部骨折的多变量校正风险比(HR)为0.78(95%CI 0.51至1.17)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

UNLABELLED: By using propensity-score matched cohorts, we compared the risk of incident hip fracture between melatonin initiators and hypnotic benzodiazepines initiators. The initiation of melatonin was not associated with an increased risk of hip fracture. INTRODUCTION: Melatonin is hypothesized to suppress bone loss, but a previous study reported an increased risk of hip fracture among melatonin users compared with non-users, which was however susceptible to confounding by indication. This study aimed to compare the risk of hip fracture between melatonin initiators and initiators of its active comparators, i.e., hypnotic benzodiazepines. METHODS: Among individuals aged 40 years or older without a history of hip fracture or cancer in the IQVIA Medical Research Database (IMRD) in the UK (2000-2018), a propensity score-matched cohort study was conducted to examine the association of melatonin initiation vs. hypnotic benzodiazepines initiation with the risk of hip fracture. RESULTS: After propensity score matching, 9,038 patients were included (4,519 melatonin initiators and 4,519 hypnotic benzodiazepines initiators). During the entire follow-up, 41 cases of hip fracture occurred in the melatonin cohort, and 51 cases occurred in the hypnotic benzodiazepines cohort. The absolute rate difference in hip fracture between melatonin initiators and hypnotic benzodiazepines initiators was -0.8 (95% CI: -1.9 to 0.3) per 1000 person-years and the multivariable-adjusted hazard ratio (HR) of hip fracture for melatonin initiators was 0.78 (95% CI: 0.51 to 1.17). CONCLUSION: In this population-based cohort study, the risk of hip fracture among melatonin initiators was not higher, if not lower, than that among hypnotic benzodiazepines initiators.

来源:Osteoporos Int,查看原文。版权归原作者所有。

引用

  1. Yang T, Wu J, Ding X, et al. The association of melatonin use and hip fracture: a matched cohort study. Osteoporos Int. 2023. PMID: 37036474. doi:10.1007/s00198-023-06740-8

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。